Defining pediatric sepsis by different criteria: discrepancies in populations and implications for clinical practice

Scott L Weiss1, Brandon Parker, Maria E Bullock

  • 1Divisions of Critical Care, Department of Pediatrics, Children's Memorial Hospital, Chicago, IL, USA.

Insights

Pediatric severe sepsis/septic shock criteria show moderate agreement, impacting data extrapolation. Clinically diagnosed sepsis patients may not meet research or administrative criteria, highlighting selection differences.

Area of Science:

  • Pediatric critical care medicine
  • Epidemiology
  • Health services research

Background:

  • Pediatric severe sepsis and septic shock are identified using distinct clinical, research, and administrative criteria.
  • The varying definitions can affect the comparability of data across different healthcare settings and studies.
  • Understanding the agreement and discrepancies between these criteria is crucial for accurate patient cohort identification.

Purpose of the Study:

  • To quantify the agreement among different criteria used for identifying pediatric severe sepsis/septic shock.
  • To detect systematic differences in patient characteristics between cohorts identified by distinct criteria.
  • To assess the implications of criterion overlap for data extrapolation in pediatric sepsis research.

Main Methods:

  • An observational cohort study was conducted in a 42-bed pediatric intensive care unit.
  • 1,729 patients aged 18 years or younger were analyzed.
  • Agreement was assessed using Cohen's kappa (κ) for research, clinical, and administrative criteria; patient characteristics were compared between groups.

Main Results:

  • The incidence of pediatric severe sepsis/septic shock was similar across criteria (5.2% research, 5.6% clinical, 6.0% administrative).
  • Moderate agreement was observed between criteria (κ values ranging from 0.52 to 0.67).
  • The research cohort had higher severity scores and greater need for vasoactive infusions compared to clinical and administrative cohorts.

Conclusions:

  • Despite similar incidence rates, there is only moderate agreement in patient identification across research, clinical, and administrative criteria for pediatric severe sepsis/septic shock.
  • A significant proportion of clinically diagnosed sepsis patients did not meet research or administrative criteria, impacting study validity.
  • Differences in patient selection necessitate careful consideration when extrapolating pediatric sepsis data across settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: